Results: 1 to 8 of 8
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
CMT Advanced Evaluation - Nonprevalent Axonal Athena Diagnostics United States | 13 | 11 |
|
Atypical Spinal Muscular Atrophy Advanced Sequencing Evaluation Athena Diagnostics United States | 10 | 10 |
|
CMT Advanced Evaluation - Nonprevalent Athena Diagnostics United States | 25 | 21 |
|
HSPB1 (CMT2F) DNA Sequencing Test Athena Diagnostics United States | 1 | 1 |
|
CMT Advanced Evaluation - Axonal Athena Diagnostics United States | 20 | 13 |
|
CMT Advanced Evaluation - Comprehensive Athena Diagnostics United States | 31 | 23 |
|
CMT Advanced Evaluation - Dominant, Axonal Athena Diagnostics United States | 15 | 11 |
|
CMT Advanced Evaluation - Dominant Athena Diagnostics United States | 18 | 13 |
|
Results: 1 to 8 of 8
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.